Polyaspartamide,
derived from polysuccinimide (PSI), has the advantage
of conveniently presenting desired functional groups by ring-opening
addition of amine-based nucleophiles to the succinimidyl ring moieties
of PSI. Using diamines with varying lengths of poly(ethylene glycol)
linker, polyaspartamide presenting amine groups with controllable
grafting density and length, namely, poly(2-hydroxyethyl aspartamide)-g-amino-poly(ethylene glycol) (PHEA–PEGAm) could
be synthesized. This PHEA–PEGAm was then used to develop in
situ forming hydrogels by Schiff base formation with aldehyde-containing
alginate (Alg-ALD). By modulating the graft architecture (i.e., grafting
length and density), the mechanical properties of the resulting Alg-PHEA
hydrogels could be controlled in a broad range. Remarkably, the hydrogels
were shown to undergo facile degradation and complete dissolution
in physiological conditions, regardless of hydrogel mechanics, by
the expedited hydrolysis through the action of remaining amine groups,
which was also heavily influenced by the graft architecture. Moreover,
the rate of degradation could be further controlled by additional
ionic cross-linking of alginate. The potential application as an injectable
drug delivery system was demonstrated by measuring drug release kinetics
and monitoring degradation ex vivo.